Imelda S. Quinlin

Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer

Mark J. Dobrzanski, Kathleen Rewers‐Felkins, Khaliquzzaman Samad et al. · Cancer Immunology Immunotherapy · 2011 · 49 citations

Life Sciences, Immunology, Oncology +16

Cytotoxic T-lymphocyte Immunotherapy for Ovarian Cancer

Stephen E. Wright, Kathleen Rewers‐Felkins, Imelda S. Quinlin et al. · Journal of Immunotherapy · 2012 · 36 citations

Medicine, Immunology, Oncology +17

Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival

Mark J. Dobrzanski, Kathleen Rewers‐Felkins, Imelda S. Quinlin et al. · Clinical Immunology · 2009 · 36 citations

Medicine, Immunology, Oncology +16

Tumor Burden Influences Cytotoxic T Cell Development in Metastatic Breast Cancer Patients—A Phase I/II Study

Stephen E. Wright, Kathleen Rewers‐Felkins, Imelda S. Quinlin et al. · Immunological Investigations · 2009 · 21 citations

Medicine, Immunology, Oncology +17

Context of MUC1 epitope: Immunogenicity

Imelda S. Quinlin, Janet S. Burnside, Kirk Dombrowski et al. · Oncology Reports · 2007 · 18 citations · Full text

Life Sciences, Immunology, Molecular Biology +12